Recruiting Prurigo Nodularis Studies in Boca Raton
A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN1)
The purpose of this study is to evaluate effect of povorcitinib on itch and skin lesions in participants with prurigo nodularis....
A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN2)
The purpose of this study is to evaluate effect of povorcitinib on itch and skin lesions in participants with prurigo nodularis....
About Prurigo Nodularis Clinical Trials in Boca Raton
Prurigo nodularis is a chronic skin condition characterized by intensely itchy, hard lumps on the skin that develop from repeated scratching. It significantly impacts quality of life and sleep. Treatment includes topical therapies, phototherapy, and newer targeted biologics.
There are currently 2 prurigo nodularis clinical trials recruiting participants in Boca Raton, FLORIDA. These studies are seeking a combined 660 participants. Research is being sponsored by Incyte Corporation. Clinical trial participation is free and participants receive study-related medical care at no cost.
Prurigo Nodularis Clinical Trials in Boca Raton — FAQ
Are there prurigo nodularis clinical trials in Boca Raton?
Yes, there are 2 prurigo nodularis clinical trials currently recruiting in Boca Raton, FLORIDA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Boca Raton?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Boca Raton research site will contact you about next steps.
Are clinical trials in Boca Raton free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Boca Raton studies also compensate for your time and travel.
What prurigo nodularis treatments are being tested?
The 2 active trials in Boca Raton are testing new therapies including novel drugs, biologics, and treatment approaches for prurigo nodularis.
Data updated March 2, 2026 from ClinicalTrials.gov